Martin A Walter Selected Research

yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acid

4/2012	Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers.
6/2011	Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers.
5/2009	[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial.
11/2007	Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial.
2/2005	Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin A Walter Research Topics

Disease

17	Neoplasms (Cancer) 01/2019 - 02/2005
7	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2019 - 01/2013
4	Thyroid Neoplasms (Thyroid Cancer) 01/2019 - 10/2007
4	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2010
3	Meningioma (Meningiomas) 01/2021 - 02/2015
3	Hyperthyroidism 10/2016 - 03/2003
3	medullary Thyroid cancer 02/2011 - 11/2007
2	Disease Progression 01/2021 - 01/2010
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 03/2015
2	Diabetes Mellitus 01/2017 - 01/2017
2	Graves Disease (Basedow Disease) 10/2016 - 01/2010
2	Adenoma (Adenomas) 10/2016 - 06/2006
2	Goiter 10/2016 - 01/2010
2	Gastrinoma 01/2015 - 04/2011
2	Brain Neoplasms (Brain Tumor) 03/2012 - 10/2010
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Thyroid Nodule (Nodule, Thyroid) 08/2019
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2019
1	Anaplastic Thyroid Carcinoma 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Thyrotoxicosis 10/2016
1	Graves Ophthalmopathy 10/2016
1	Melanoma (Melanoma, Malignant) 08/2014
1	Glioblastoma (Glioblastoma Multiforme) 08/2014
1	Sarcoma (Soft Tissue Sarcoma) 03/2012
1	Vasculitis (Vasculitides) 02/2012
1	Lymphoma (Lymphomas) 08/2010
1	Infections 01/2010
1	Hyperplasia 01/2010
1	Sepsis (Septicemia) 01/2010
1	Paraganglioma (Paragangliomas) 04/2009
1	Pheochromocytoma 04/2009
1	Sialadenitis 10/2007
1	Xerostomia 10/2007
1	Hypothyroidism 03/2007
1	Follicular Adenocarcinoma 10/2006
1	Carcinoma (Carcinomatosis) 06/2006
1	Papillary Carcinoma 06/2006

Drug/Important Bio-Agent (IBA)

8	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2015 - 09/2005
8	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2013 - 02/2005
7	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021 - 02/2005
5	Radioisotopes (Radionuclides)IBA 01/2021 - 09/2005
5	yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA 04/2012 - 02/2005
5	AcidsIBA 04/2012 - 09/2005
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2009
3	Peptide Receptors (Peptide Receptor)IBA 01/2021 - 04/2011
3	IodineIBA 01/2019 - 05/2009
3	edotreotide lutetium LU-177IBA 07/2015 - 01/2015
3	Octreotide (Sandostatin)FDA LinkGeneric 04/2012 - 09/2005
2	Edotreotide (SMT 487)IBA 03/2017 - 01/2017
2	DOTA-Tyr(3)- 90Y-octreotideIBA 01/2017 - 02/2015
2	Antithyroid Agents (Antithyroid Drugs)IBA 10/2016 - 03/2007
2	LigandsIBA 03/2015 - 08/2014
2	Amino Acids FDA Link 03/2012 - 10/2010
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2012 - 02/2012
2	fluorodopa F 18IBA 03/2012 - 04/2009
2	Gemcitabine FDA Link 08/2010 - 02/2009
1	fluorocholineIBA 12/2021
1	RadiopharmaceuticalsIBA 01/2020
1	AntigensIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	technetium Tc 99m hydroxymethylene diphosphonate (Osteoscan)FDA Link 01/2018
1	somatostatin receptor 2IBA 03/2017
1	Pharmaceutical PreparationsIBA 11/2016
1	Androgen Receptors (Androgen Receptor)IBA 03/2015
1	DOTA(0)-Tyr(3)- 177Lu-octreotideIBA 02/2015
1	IntegrinsIBA 08/2014
1	Peptide Hydrolases (Proteases)FDA Link 08/2013
1	TriazolesIBA 08/2013
1	PeptidomimeticsIBA 08/2013
1	AmidesIBA 08/2013
1	Technetium Tc 99m MedronateIBA 03/2012
1	GastrinsIBA 04/2011
1	Proton Pump InhibitorsIBA 04/2011
1	vandetanib (ZD6474)IBA 02/2011
1	Codon (Codons)IBA 01/2011
1	Antineoplastic Agents (Antineoplastics)IBA 08/2010
1	Glucose (Dextrose)FDA LinkGeneric 08/2010
1	ProcalcitoninIBA 01/2010
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2010
1	Thyroglobulin FDA Link 05/2009
1	3-Tyr-octreotideIBA 05/2009
1	YttriumIBA 05/2009
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 04/2009
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 04/2009
1	ProdrugsIBA 02/2009
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2009
1	NucleosidesIBA 02/2009
1	ras GTPase-Activating Proteins (ras-GAP)IBA 07/2007
1	SugarsIBA 01/2007
1	Iodine-131IBA 10/2006
1	RNA (Ribonucleic Acid)IBA 06/2006

Therapy/Procedure

21	Therapeutics 01/2021 - 09/2005
3	Radiotherapy 01/2013 - 02/2005
2	Aftercare (After-Treatment) 01/2017 - 02/2015
2	Drug Therapy (Chemotherapy) 08/2010 - 02/2009
1	Neck Dissection (Radical Neck Dissection) 01/2019
1	Thyroidectomy 01/2010
1	Tooth Extraction (Tooth Extractions) 10/2007